Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.

Disease activity Disease outcome Eosinophilic esophagitis Histology

Journal

International archives of allergy and immunology
ISSN: 1423-0097
Titre abrégé: Int Arch Allergy Immunol
Pays: Switzerland
ID NLM: 9211652

Informations de publication

Date de publication:
20 Oct 2023
Historique:
received: 21 06 2023
accepted: 23 08 2023
medline: 23 10 2023
pubmed: 23 10 2023
entrez: 22 10 2023
Statut: aheadofprint

Résumé

It is still unknown whether eosinophilic esophagitis (EoE) patients with localized disease are different from those with extended disease. We evaluated prospectively included patients in the Swiss EoE cohort. Data on all patients with active disease at baseline, no concomitant gastroesophageal reflux disease, no strictures at baseline, and at least one follow-up visit were analyzed. We compared patients with histologically localized proximal versus distal versus extended (=proximal and distal) disease with regard to patient, disease characteristics, disease presentation, and development of complications. We included 124 patients with a median of 2.5 years of follow-up (73.4% males, median age 35.0 years). Ten patients had proximal (8.1%), 46 patients had distal (37.1%), and 68 patients had extended disease (54.8%). Patients with proximal disease were significantly more often females (80%) compared with patients with distal (26.1%, p = 0.002) or extended disease (19.1%, p < 0.001) and reported less severe symptoms (VAS 0 vs. VAS 1, p = 0.001). Endoscopic and histological disease was less pronounced in the proximal esophagus of proximal EoE compared to extended disease (EREFS 1.0 vs. 3.0, p = 0.001; 27.0 eos/hpf vs. 52.5 eos/hpf, p = 0.008). Patients with proximal disease were less likely to undergo dilation compared to patients with distal disease in the follow-up (3.3% vs. 23.3%, p = 0.010). In a multivariate Cox regression model, proximal eosinophilia was less likely to be associated with treatment failure compared to distal eosinophilia. Although isolated proximal EoE is infrequent, it is associated with less severe disease and better disease outcome. Proximal disease appears to present a unique EoE phenotype.

Identifiants

pubmed: 37866349
pii: 000533815
doi: 10.1159/000533815
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Alexis Heil (A)

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.

Tobias Kuehlewindt (T)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Department of Internal Medicine, GZO Zurich Regional Health Center, Wetzikon, Switzerland.

Anne Godat (A)

Department of Internal Medicine, GZO Zurich Regional Health Center, Wetzikon, Switzerland.

Hans-Uwe Simon (HU)

Institute of Pharmacology, University of Bern, Bern, Switzerland.
Institute of Biochemistry, Brandenburg Medical School, Neuruppin, Germany.

Dagmar Simon (D)

Department of Dermatology, Inselspital, Bern University Hospital, Bern, Switzerland.

Philipp Schreiner (P)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Catherine Saner (C)

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.

Stephan R Vavricka (SR)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Luc Biedermann (L)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Ekaterina Safroneeva (E)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Jean-Benoit Rossel (JB)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Andreas Limacher (A)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Alex Straumann (A)

Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.

Alain M Schoepfer (AM)

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.

Thomas Greuter (T)

Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.
Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
Department of Internal Medicine, GZO Zurich Regional Health Center, Wetzikon, Switzerland.

Classifications MeSH